Antimicrobial resistance is not just a pressing global health crisis, but also a crisis of innovation

ALTERBIOTIC investigates current efforts to rebuild the antimicrobial innovation ecosystem by examining how key actors from science, industry, and policy imagine and pursue robust solutions to the AMR health and innovation crisis. Empirically, the project maps emerging alternative clinical, regulatory, and economic approaches to drive biomedical R&D in this field and analyses the complex political and technical ‘innovation challenges’ related to the timely, sustainable, and equitable development of new, effective antibacterial therapies.

About →

We investigate the innovations that are currently pursued


ALTERBIOTIC develops a unique social science research approach to conceptualize the emerging antimicrobial innovation initiatives that were created in response to the AMR global crisis and the decline in antibiotic R&D. ALTERBIOTIC investigates in depth how these emerging initiatives and alliances aim to impinge on frameworks and regimes governing antimicrobial development, distribution and use – and whether and to which extent these challenge existing modes of innovation by creating alternative modes of innovation in the antimicrobial space.

Research →
The AlterBiotic research proposal

Meet the ALTERBIOTIC team


Investigating the AMR innovation challenge requires multidisciplinary collaboration: Our social science team brings together researchers with diverse disciplinary backgrounds and areas of expertise, including Science and Technology Studies (STS), medical sociology, the history of medicine and public health, innovation policy studies, and medicinal chemistry. Together, we explore the emerging ‘alter-biotic’ innovation space through close collaboration in conceptual work, shared field-research activities, and individual subprojects.

Team →
The AlterBiotic team

All the Latest
: News, Events, and More

Find out more here →